What is the clinical significance of a 77-year-old woman with an uncorrected secundum Atrial Septal Defect (ASD) who developed Heart Failure with reduced Ejection Fraction (HFrEF) and atrial fibrillation with Rapid Ventricular Response (RVR), then underwent transcatheter ASD closure with partial Ejection Fraction (EF) recovery but persistent atrial fibrillation (AFib)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

This case of a 77-year-old woman with an uncorrected secundum atrial septal defect (ASD) who developed heart failure with reduced ejection fraction (HFrEF) and atrial fibrillation (AFib) with rapid ventricular response (RVR) in her 70s, followed by transcatheter ASD closure with partial ejection fraction recovery but persistent AFib, is moderately clinically significant and potentially publication-worthy. The case is notable because ASD closure is typically performed much earlier in life, and the development of HFrEF in this setting represents an uncommon complication of long-standing uncorrected ASD, as suggested by the 2018 AHA/ACC guideline for the management of adults with congenital heart disease 1.

Key Points

  • The teaching value lies in demonstrating that even elderly patients with long-standing ASDs can benefit from closure, particularly when they develop complications like heart failure, with studies showing improvement in functional status and right ventricular size and function after repair 1.
  • The partial recovery of ejection fraction after closure in an elderly patient illustrates that intervention can still be beneficial despite advanced age and chronicity of the defect.
  • The persistent AFib despite closure highlights the irreversible atrial remodeling that occurs with long-standing volume overload, as noted in a systematic review of interventional therapy versus medical therapy for secundum ASD 1.
  • For publication, the case would be strengthened by including detailed hemodynamic data before and after closure, cardiac MRI findings if available, and long-term follow-up data showing the durability of the heart failure improvement.

Research and Teaching Value

The research value includes contributing to our understanding of the natural history of uncorrected ASDs into late adulthood and the potential benefits of intervention even at advanced ages when complications develop, with recent guidelines emphasizing the importance of considering closure in adults with significant shunting and symptoms 1. Some key considerations for management and potential publication include:

  • The impact of ASD closure on atrial arrhythmias, with studies suggesting that closure may not significantly reduce the incidence of AFib in patients over 50 years of age 1.
  • The role of cardiac catheterization in evaluating patients with ASD, particularly in determining detailed hemodynamics for decision-making or clarifying discrepant noninvasive imaging data 1.

From the Research

Clinical Significance

  • The case of a 77-year-old woman with an uncorrected secundum ASD, who developed HFrEF and atrial fibrillation with RVR in her 70s, then underwent transcatheter ASD closure with partial EF recovery but persistent AFib, is clinically significant due to the coexistence of atrial fibrillation and heart failure with reduced ejection fraction, which is associated with worse outcomes 2, 3, 4.
  • The patient's condition is unique in that she underwent transcatheter ASD closure, which is a relatively rare procedure in patients with HFrEF and atrial fibrillation, and experienced partial EF recovery but persistent AFib.

Teaching and Research Values

  • This case has teaching value as it highlights the importance of considering the type of heart failure and its impact on prognosis in patients with atrial fibrillation 2.
  • The case also has research value as it contributes to the understanding of the relationship between atrial fibrillation, heart failure with reduced ejection fraction, and transcatheter ASD closure, which is an area of ongoing research 3, 4, 5.
  • The patient's outcome, including partial EF recovery but persistent AFib, raises questions about the optimal management of atrial fibrillation in patients with HFrEF and the potential benefits and limitations of transcatheter ASD closure in this population 6, 5.

Publication-Worthiness

  • The case may be considered publication-worthy due to its unique combination of conditions and the patient's outcome, which could contribute to the existing literature on the management of atrial fibrillation and heart failure with reduced ejection fraction 2, 3, 4, 5.
  • The case could be published as a case report or a retrospective study, highlighting the clinical significance and teaching and research values of the patient's condition and outcome.

Related Questions

For a patient with persistent Atrial Fibrillation (AFib) and heart failure with reduced Ejection Fraction (EF) on metoprolol tartrate, is switching to metoprolol succinate or carvedilol better?
What is the next step for a 93-year-old male with a history of atherosclerosis, aortic and mitral valve disease, and a pacemaker, who has chronic heart failure and atrial fibrillation (A. Fib), and is experiencing increased left foot swelling while on coumadin (warfarin)?
What is the significance of a 4.2 second pause in a patient with atrial fibrillation (Afib) and a history of Afib, currently on digoxin (Digitalis) 125 micrograms daily?
What is the management of atrial fibrillation (AFib) with rapid ventricular response (RVR) in a patient with heart failure with reduced ejection fraction (HFrEF)?
What is the management approach for a 63-year-old male with reduced left ventricular function (ejection fraction 35%), history of atrial fibrillation, status post ablation, experiencing premature ventricular complex (PVC) breakthrough despite pacing at 90-100 beats per minute with an Assurity (pacemaker) device?
What are the treatment options for Benign Prostatic Hyperplasia (BPH)?
Would a 68-year-old female with low ferritin (iron storage protein) levels, normocytic anemia (indicated by Red Blood Cell (RBC) count of 5.05, Hemoglobin (Hb) of 12.4, hematocrit (Hct) of 39.7, Mean Corpuscular Volume (MCV) of 79, Mean Corpuscular Hemoglobin (MCH) of 24.6, and Mean Corpuscular Hemoglobin Concentration (MCHC) of 31.2) be considered to have iron deficiency anemia?
When to initiate anticoagulation (anticoagulant) therapy post-operatively?
What non-steroidal medication (NSAID) can treat Crohn's disease?
What is the maximal oxygen uptake (VO2 max) of female athletes?
What is a suitable medication to calm an agitated senior citizen (elderly patient) in an inpatient setting?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.